Works matching IS 00912700 AND DT 2013 AND VI 53 AND IP 11

Results: 16

Reduced exposure variability of the CYP3A substrate simvastatin by dose individualization to CYP3A activity.

Published in:

Journal of Clinical Pharmacology, 2013, v. 53, n. 11, p. 1199, doi. 10.1002/jcph.161

By:

Stoll, Felicitas;
Burhenne, Jürgen;
Lausecker, Berthold;
Weiss, Johanna;
Thomsen, Torben;
Haefeli, Walter Emil;
Mikus, Gerd

Publication type:

Article

Influence of food on pharmacokinetics of zolpidem from fast dissolving sublingual zolpidem tartrate tablets.

Published in:

Journal of Clinical Pharmacology, 2013, v. 53, n. 11, p. 1194, doi. 10.1002/jcph.159

By:

Greenblatt, David J.;
Harmatz, Jerold S.;
Singh, Nikhilesh N.;
Roth, Thomas;
Harris, Stephen C.;
Kapil, Ram P.

Publication type:

Article

Safety, tolerability, and pharmacokinetics of oral and intravenous administration of GSK1322322, a peptide deformylase inhibitor.

Published in:

Journal of Clinical Pharmacology, 2013, v. 53, n. 11, p. 1168, doi. 10.1002/jcph.150

By:

Naderer, Odin J.;
Jones, Lori S.;
Zhu, John;
Kurtinecz, Milena;
Dumont, Etienne

Publication type:

Article

Issue Information.

Published in:: Journal of Clinical Pharmacology, 2013, v. 53, n. 11, p. 1103, doi. 10.1002/jcph.183
Publication type:: Article

Founding an adverse drug reaction (ADR) network: A method for improving doctors spontaneous ADR reporting in a general hospital.

Published in:

Journal of Clinical Pharmacology, 2013, v. 53, n. 11, p. 1220, doi. 10.1002/jcph.149

By:

Goldstein, Lee Hilary;
Berlin, Maya;
Saliba, Walid;
Elias, Mazen;
Berkovitch, Matitiyahu

Publication type:

Article

Co-medication of pravastatin and paroxetine-A categorical study.

Published in:

Journal of Clinical Pharmacology, 2013, v. 53, n. 11, p. 1212, doi. 10.1002/jcph.151

By:

An, Li;
Ravindran, Priyadarshini P.;
Renukunta, Swetha;
Denduluri, Srinivas

Publication type:

Article

Impact of donor and recipient CYP3A5 and ABCB1 genetic polymorphisms on tacrolimus dosage requirements and rejection in Caucasian Spanish liver transplant patients.

Published in:

Journal of Clinical Pharmacology, 2013, v. 53, n. 11, p. 1146, doi. 10.1002/jcph.154

By:

Gómez‐Bravo, Miguel Angel;
Salcedo, Magdalena;
Fondevila, Constantino;
Suarez, Francisco;
Castellote, José;
Rufian, Sebastián;
Pons, José Antonio;
Alamo, José María;
Millán, Olga;
Brunet, Mercè

Publication type:

Article

Integration of biostatistics and pharmacometrics computing platforms for efficient and reproducible PK/PD analysis: A case study.

Published in:

Journal of Clinical Pharmacology, 2013, v. 53, n. 11, p. 1112, doi. 10.1002/jcph.157

By:

Ou, Ying C.;
Lo, Arthur;
Lee, Brian;
Liu, Phillip;
Kimura, Karen;
Eary, Charisse;
Hopkins, Alan

Publication type:

Article

Influence of fludarabine on the pharmacokinetics of oral busulfan during pretransplant conditioning for hematopoietic stem cell transplantation.

Published in:

Journal of Clinical Pharmacology, 2013, v. 53, n. 11, p. 1205, doi. 10.1002/jcph.130

By:

de Castro, Francine Attié;
Lanchote, Vera Lucia;
Voltarelli, Julio Cesar;
Colturato, Virgílio Antônio Rensi;
Simões, Belinda Pinto

Publication type:

Article

Safety, tolerability, pharmacokinetics, and pharmacodynamics of macitentan, an endothelin receptor antagonist, in an ascending multiple-dose study in healthy subjects.

Published in:

Journal of Clinical Pharmacology, 2013, v. 53, n. 11, p. 1131, doi. 10.1002/jcph.152

By:

Sidharta, Patricia N.;
van Giersbergen, Paul L. M.;
Dingemanse, Jasper

Publication type:

Article

Multiple-dose, safety, pharmacokinetic, and pharmacodynamic study of sotatercept (ActRIIA-IgG1), a novel erythropoietic agent, in healthy postmenopausal women.

Published in:

Journal of Clinical Pharmacology, 2013, v. 53, n. 11, p. 1121, doi. 10.1002/jcph.160

By:

Sherman, Matthew L.;
Borgstein, Niels G.;
Mook, Louisa;
Wilson, Dawn;
Yang, Yijun;
Chen, Nianhang;
Kumar, Ravindra;
Kim, Kenneth;
Laadem, Abderrahmane

Publication type:

Article

Population pharmacokinetics of ceftaroline in patients with acute bacterial skin and skin structure infections or community-acquired bacterial pneumonia.

Published in:

Journal of Clinical Pharmacology, 2013, v. 53, n. 11, p. 1155, doi. 10.1002/jcph.153

By:

Van Wart, Scott A.;
Forrest, Alan;
Khariton, Tatiana;
Rubino, Christopher M.;
Bhavnani, Sujata M.;
Reynolds, Daniel K.;
Riccobene, Todd;
Ambrose, Paul G.

Publication type:

Article

Effects of polymorphisms of the SLCO2B1 transporter gene on the pharmacokinetics of montelukast in humans.

Published in:

Journal of Clinical Pharmacology, 2013, v. 53, n. 11, p. 1186, doi. 10.1002/jcph.144

By:

Kim, Kyoung‐Ah;
Lee, Hye‐Mi;
Joo, Hyun‐Jin;
Park, In‐Bae;
Park, Ji‐Young

Publication type:

Article

Pharmacokinetics and pharmacodynamics of vincristine sulfate liposome injection (VSLI) in adults with acute lymphoblastic leukemia.

Published in:

Journal of Clinical Pharmacology, 2013, v. 53, n. 11, p. 1139, doi. 10.1002/jcph.155

By:

Silverman, Jeffrey A.;
Reynolds, Laurie;
Deitcher, Steven R.

Publication type:

Article

Doxylamine pharmacokinetics following single dose oral administration in children ages 2-17 years.

Published in:

Journal of Clinical Pharmacology, 2013, v. 53, n. 11, p. 1177, doi. 10.1002/jcph.137

By:

Balan, Guhan;
Thompson, Gary A.;
Gibb, Roger;
Li, Lijuan;
Hull, David;
Seeck, Molly

Publication type:

Article

Population pharmacokinetic analysis from phase I and phase II studies of the humanized monovalent antibody, onartuzumab (MetMAb), in patients with advanced solid tumors.

Published in:

Journal of Clinical Pharmacology, 2013, v. 53, n. 11, p. 1103, doi. 10.1002/jcph.148

By:

Xin, Yan;
Jin, Denise;
Eppler, Stephen;
Damico‐Beyer, Lisa A.;
Joshi, Amita;
Davis, John D.;
Kaur, Surinder;
Nijem, Ihsan;
Bothos, John;
Peterson, Amy;
Patel, Premal;
Bai, Shuang

Publication type:

Article